| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Coagulation factor V inhibitors, a review of the case report literature
|
Wada, Hideo
|
|
|
4 |
C |
p.
|
artikel
|
| 2 |
Comparison of percent adjusted versus predefined incremental argatroban dosing nomograms in patients with heparin induced thrombocytopenia
|
Jao, Mark
|
|
|
4 |
C |
p.
|
artikel
|
| 3 |
Global coagulation assays to measure in vitro fibrinolysis
|
Dias, Joao D.
|
|
|
4 |
C |
p.
|
artikel
|
| 4 |
Incidence, risk factors and clinical outcome of venous thromboembolism in non-small cell lung cancer patients receiving immune checkpoint inhibition
|
Bjørnhart, Birgitte
|
|
|
4 |
C |
p.
|
artikel
|
| 5 |
No changes of parameters nor coagulation activation in healthy subjects vaccinated for SARS-Cov-2
|
Peyvandi, Flora
|
|
|
4 |
C |
p.
|
artikel
|
| 6 |
Rivaroxaban and medication adherence – A cohort study (RIVA): Qualitative results
|
Dotta-Celio, Jennifer
|
|
|
4 |
C |
p.
|
artikel
|
| 7 |
Systematic review of treatment gaps in oral anticoagulant use in atrial fibrillation
|
Paquette, Miney
|
|
|
4 |
C |
p.
|
artikel
|
| 8 |
The use of apixaban as a perioperative bridge for warfarin in a patient unable to use parenteral anticoagulation: A case report
|
Dietrich, Eric A.
|
|
|
4 |
C |
p.
|
artikel
|
Tijdschrift beschrijving